ブックタイトルカテーテル関連尿路感染の予防のためのCDCガイドライン 2009｜株式会社メディコン

概要

カテーテル関連尿路感染の予防のためのCDCガイドライン 2009｜株式会社メディコン

VI. SurveillanceA. Consider surveillance for CAUTI when indicated by facility-based risk assessment.(Category II)1. Identify the patient groups or units on which to conduct surveillance based onfrequency of catheter use and potential risk of CAUTI.B. Use standardized methodology for performing CAUTI surveillance. (Category IB)1. Examples of metrics that should be used for CAUTI surveillance include:a. Number of CAUTI per 1000 catheter-daysb. Number of bloodstream infections secondary to CAUTI per 1000 catheter-daysc. Catheter utilization ratio: (urinary catheter days/patient days) x 1002. Use CDC/NHSN criteria for identifying patients who have symptomatic UTI (SUTI)(numerator data) (see NHSN Patient Safety Manual:http://www.cdc.gov/nhsn/library.html).3. For more information on metrics, please see the U.S. Department of Health & HumanServices (HHS) Action Plan to Prevent Healthcare-Associated Infections:http://www.hhs.gov/ophs/initiatives/hai/infection.html.C. Routine screening of catheterized patients for asymptomatic bacteriuria (ASB) is notrecommended. (Category II) (Key Question 2D)原文D. When performing surveillance for CAUTI, consider providing regular (e.g., quarterly)feedback of unit-specific CAUTI rates to nursing staff and other appropriate clinical carestaff. (Category II) (Key Question 2D)66 < 原文 > II. Summary of Recommendations